RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Embla Medical hf Stock

Embla Medical hf Stocks 2025

Embla Medical hf Stocks

420.3 M

Ticker

EMBLA.CO

ISIN

IS0000000040

WKN

755122

In 2025, Embla Medical hf had 420.3 M outstanding stocks, a 0% change from the 420.3 M stocks in the previous year.

The Embla Medical hf Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2030e420.3
2029e420.3
2028e420.3
2027e420.3
2026e420.3
2025e420.3
2024e420.3
2023420.3
2022417.83
2021422.8
2020422.73
2019424.57
2018426.48
2017432.45
2016440.68
2015445.66
2014452.7
2013449.6
2012448.7
2011451.7
2010455
2009429.8
2008423
2007394.4
2006384.3
2005331.9
2004317.4

Embla Medical hf shares outstanding

The number of shares was Embla Medical hf in 2024 — This indicates how many shares 420.297 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Embla Medical hf earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Embla Medical hf's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Embla Medical hf’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Embla Medical hf's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Embla Medical hf Aktienanalyse

What does Embla Medical hf do?

Ossur hf is an Icelandic company specializing in the development and manufacturing of orthopedic products. The company was founded in 1971 by Orn Ragnarsson and has since brought many innovative products to the market. The company is headquartered in Reykjavik, Iceland, and operates in more than 30 countries worldwide. Furthermore, the company collaborates with partners and distributors from around the world. Ossur's products are intended for people with amputations, injuries, or chronic pain. Ossur's business model is to develop and manufacture high-quality, innovative solutions for the orthopedic industry. Ossur's products aim to improve the mobility, comfort, and quality of life for people with disabilities and injuries. Ossur operates in three main divisions: prosthetics, braces, and motion analysis. The prosthetics division focuses on the development of artificial limbs for people who have undergone amputation. The braces division focuses on the development of products such as knee braces, back braces, and ankle braces to support people with injuries or chronic pain. The motion analysis division focuses on the development of products such as motion measurement systems and gait analysis devices to assist orthopedic experts in diagnosing and treating patients. One of Ossur's most well-known products is the "Flex-Foot" leg prosthesis. The design of this prosthesis is based on the natural movements of a human foot and is a milestone in prosthetic development. Another innovative product from Ossur is the "Rheo" knee joint system, which is based on artificial intelligence and allows the user to walk more naturally. In recent years, Ossur has also expanded its product portfolio to the field of sports. The company has developed a range of products to help athletes improve their performance, avoid injuries, and heal faster. Overall, Ossur has shown in recent years that the company is always looking for new opportunities to develop innovative solutions in the field of orthopedics. Through a focus on research and development and collaboration with leading orthopedic experts, Ossur has established itself as a key player in the market. Embla Medical hf ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Embla Medical hf's Shares Outstanding

Embla Medical hf's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Embla Medical hf’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Embla Medical hf’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Embla Medical hf’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Embla Medical hf stock

How many stocks are there of Embla Medical hf?

The current number of stocks of Embla Medical hf is 420.3 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Embla Medical hf are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Embla Medical hf evolved in recent years?

The number of shares of Embla Medical hf has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Embla Medical hf as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Embla Medical hf?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Embla Medical hf pay?

Over the past 12 months, Embla Medical hf paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 3.17 %. For the coming 12 months, Embla Medical hf is expected to pay a dividend of 1.44 USD.

What is the dividend yield of Embla Medical hf?

The current dividend yield of Embla Medical hf is 3.17 %.

When does Embla Medical hf pay dividends?

Embla Medical hf pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Embla Medical hf?

Embla Medical hf paid dividends every year for the past 7 years.

What is the dividend of Embla Medical hf?

For the upcoming 12 months, dividends amounting to 1.44 USD are expected. This corresponds to a dividend yield of 30.48 %.

In which sector is Embla Medical hf located?

Embla Medical hf is assigned to the 'Health' sector.

Wann musste ich die Aktien von Embla Medical hf kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Embla Medical hf from 3/26/2020 amounting to 0.15 USD, you needed to have the stock in your portfolio before the ex-date on 3/13/2020.

When did Embla Medical hf pay the last dividend?

The last dividend was paid out on 3/26/2020.

What was the dividend of Embla Medical hf in the year 2024?

In the year 2024, Embla Medical hf distributed 0 USD as dividends.

In which currency does Embla Medical hf pay out the dividend?

The dividends of Embla Medical hf are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Embla Medical hf

Our stock analysis for Embla Medical hf Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Embla Medical hf Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.